Biotech Values

[io_io]

"GTCB has proposed that the pivotal U.S. ATryn trial have an active arm of 17 patients with hereditary antithrombin deficiency and an historical control arm of 35 patients."

Was this approved by the FDA ?

(I mean the Control Arm, not just the Pool Data you referred to)